Literature DB >> 2186438

[The role of echotomography in sports traumatology of the lower extremity].

R Campani1, O Bottinelli, E Genovese, A Bozzini, F Benazzo, G Barnabei, G P Jelmoni, E Carella.   

Abstract

Sonography, which is commonly used in the evaluation of muscular traumas following exercise, quite often provides the radiologist with normal findings. One hundred and fifty-nine athletes were considered (170 US examinations), and the clinical diagnoses the patients had been referred for were compared with US findings: the pathologic condition was confirmed in 59% of the cases, while the extant 41% had normal findings. The highest percentage of positive findings was observed in the Achilles tendon region (75%), while the figure dropped to 38% in the thigh. In the latter location, muscular ruptures were confirmed in 69% of the cases, versus 17% in case of muscular distraction. As for the Achilles tendon, pathologic conditions both along the axis and in the insertion of the tendon were confirmed in 20% of the cases, but clinical accuracy was improved by US in 47% and 20% of the patients, respectively, and the diagnosis was changed in 10% and 20% of the cases, respectively. Therefore, clinical accuracy was demonstrated to depend on the pathologic condition as well as on the anatomical region involved.

Entities:  

Mesh:

Year:  1990        PMID: 2186438

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  2 in total

Review 1.  Subcutaneous rupture of the Achilles tendon: basic science and some aspects of clinical practice.

Authors:  S W Waterston; N Maffulli; S W Ewen
Journal:  Br J Sports Med       Date:  1997-12       Impact factor: 13.800

2.  Contrast enhanced ultrasound with second generation contrast agent for the follow-up of lower-extremity muscle-strain-repairing processes in professional athletes.

Authors:  E A Genovese; L Callegari; F Combi; A Leonardi; M G Angeretti; F Benazzo; F D'Angelo; C Fugazzola
Journal:  Radiol Med       Date:  2007-07-26       Impact factor: 3.469

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.